Director:
Yong X.Wang,PhD & MD, Professor of Biotechnology and Pharmacology and Head of King's Lab.
Members
Xinyan Li,PhD & MD, Lecturer
Ainiu Ma, PhD, Assistant Research Fellow
Bin Hao, PhD, Assistant Research Fellow
Research Field
Pain Biology
Translational Phamacology
Pharmacokinetics and Drug Metablism
Publications & Patents
1.Gong N., Xiao Q., Zhu B., Zhang C.-Y., Wang Y.-C., Han H., Ma A.-N. & Wang Y.-X. (2014). Activation of spinal glucagon like peptide-1 receptors specifically suppresses pain hypersensitivity. J. Neurosci., DOI:10.1523/JNEUROSCI.4703-13.2014.
2.Wang Y.-C., Lu J.-M., Jin H.-Z., Ma A.-N., Zhang J.-Y., Gong N., Xiao Q., Zhu B., Lv Y.-F., Yu N., Zhang W.-D. & Wang Y.-X. (2014). Beneficial effects of natural Jeju Groundwaters on lipid metabolism in high-fat diet-induced hyperlipidemic rats. Nutrition Research & Practice, doi:10.4162/nrp.2014.8.1.
3.Gong N., Li X.-Y., Xiao Q. & Wang Y.-X. (2014). Identification of a novel spinal dorsal horn astroglial D-amino acid oxidase-hydrogen peroxide pathway involved in morphine antinociceptive tolerance. Anesthesiology, doi: 10.1097/ALN.0b013e3182a66d2a.
4.Zhang J.-Y., Gong N., Huang J.-L., Guo L.-C. & Wang Y.-X. (2013). Gelsemine, a principle alkaloid from Gelsemium sempervirens Ait., exhibits potent and specific antinociception in chronic pain by acting at spinal α3 glycine receptors. Pain 154: 2452-2462.
5.Wei H., Gong N., Huang J.-L., Fan H., Ma A.-N., Li X.-Y., Wang Y.-X. & Pertovaara A. (2013). Spinal D-amino acid oxidase contributes to mechanical pain hypersensitivity induced by sleep deprivation in the rat. Pharmacol. Biochem. Behav. 111: 30-36.
6.Ma A.-N., Gong N., Lu J.-M., Huang J.-L., Hao B., Guo Y., Zhong J., Xu Y., Chang J. & Wang Y.-X. (2013). Local protective effects of oral 45S5 bioactive glass on gastric ulcers in experimental animals. J. Mat. Sci.: Mat. Med. 24: 803-809.
7.Yu G. & Wang Y.-X. (2013). GLP-1 degredation and its inhibitors in clinical development. Chin. Clin. Pharmaceut. 22: 260-264.
8.Chen Q.-F. & Wang Y.-X. (2013). Progress in clinical studies of liraglutide. World Clin. Drugs 34: 312-315.
